170 related articles for article (PubMed ID: 23471783)
1. Inflammatory markers in the second trimester prior to clinical onset of preeclampsia, intrauterine growth restriction, and spontaneous preterm birth.
Haedersdal S; Salvig JD; Aabye M; Thorball CW; Ruhwald M; Ladelund S; Eugen-Olsen J; Secher NJ
Inflammation; 2013 Aug; 36(4):907-13. PubMed ID: 23471783
[TBL] [Abstract][Full Text] [Related]
2. Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia.
Toldi G; Bíró E; Szalay B; Stenczer B; Molvarec A; Rigó J; Vásárhelyi B; Bekõ G
Clin Chem Lab Med; 2011 Nov; 49(11):1873-6. PubMed ID: 21722073
[TBL] [Abstract][Full Text] [Related]
3. Establishing a Differential Marker Profile for Pregnancy Complications Near Delivery.
Sharabi-Nov A; Kumar K; Fabjan Vodušek V; Premru Sršen T; Tul N; Fabjan T; Meiri H; Nicolaides KH; Osredkar J
Fetal Diagn Ther; 2020; 47(6):471-484. PubMed ID: 31778996
[TBL] [Abstract][Full Text] [Related]
4. Specific inflammatory profile in each pregnancy complication: A comparative study.
Brien ME; Boufaied I; Bernard N; Forest JC; Giguere Y; Girard S
Am J Reprod Immunol; 2020 Dec; 84(6):e13316. PubMed ID: 32761668
[TBL] [Abstract][Full Text] [Related]
5. Serum soluble urokinase plasminogen activator receptor (suPAR) in early pregnancy prior to clinical onset of preeclampsia.
Odden N; Henriksen T; Mørkrid L
Acta Obstet Gynecol Scand; 2012 Oct; 91(10):1226-32. PubMed ID: 22774918
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction.
Crispi F; Llurba E; Domínguez C; Martín-Gallán P; Cabero L; Gratacós E
Ultrasound Obstet Gynecol; 2008 Mar; 31(3):303-9. PubMed ID: 18058842
[TBL] [Abstract][Full Text] [Related]
7. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
Laskowska M; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
[TBL] [Abstract][Full Text] [Related]
8. The role of inflammatory markers hs-CRP, sialic acid, and IL-6 in the pathogenesis of preeclampsia and intrauterine growth restriction.
Kara AE; Guney G; Tokmak A; Ozaksit G
Eur Cytokine Netw; 2019 Mar; 30(1):29-33. PubMed ID: 31074415
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy.
Birdir C; Droste L; Fox L; Frank M; Fryze J; Enekwe A; Köninger A; Kimmig R; Schmidt B; Gellhaus A
Pregnancy Hypertens; 2018 Apr; 12():124-128. PubMed ID: 29674192
[TBL] [Abstract][Full Text] [Related]
11. Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction?
D'Anna R; Baviera G; Corrado F; Leonardi I; Buemi M; Jasonni VM
Acta Obstet Gynecol Scand; 2002 Jun; 81(6):540-3. PubMed ID: 12047308
[TBL] [Abstract][Full Text] [Related]
12. Second trimester inflammatory and metabolic markers in women delivering preterm with and without preeclampsia.
Ross KM; Baer RJ; Ryckman K; Feuer SK; Bandoli G; Chambers C; Flowers E; Liang L; Oltman S; Dunkel Schetter C; Jelliffe-Pawlowski L
J Perinatol; 2019 Feb; 39(2):314-320. PubMed ID: 30518800
[TBL] [Abstract][Full Text] [Related]
13. First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia.
Vandenberghe G; Mensink I; Twisk JW; Blankenstein MA; Heijboer AC; van Vugt JM
Prenat Diagn; 2011 Oct; 31(10):955-61. PubMed ID: 21717483
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial DNA Copy Number in Peripheral Blood in the First Trimester of Pregnancy and Different Preeclampsia Clinical Phenotypes Development: A Pilot Study.
Busnelli A; Lattuada D; Ferrari S; Reschini M; Colciaghi B; Somigliana E; Fedele L; Ferrazzi E
Reprod Sci; 2019 Aug; 26(8):1054-1061. PubMed ID: 30296910
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic biomarkers in midtrimester maternal plasma can accurately predict the development of preeclampsia.
Lee SM; Kang Y; Lee EM; Jung YM; Hong S; Park SJ; Park CW; Norwitz ER; Lee DY; Park JS
Sci Rep; 2020 Sep; 10(1):16142. PubMed ID: 32999354
[TBL] [Abstract][Full Text] [Related]
16. Can maternal serum placental growth factor estimation in early second trimester predict the occurrence of early onset preeclampsia and/or early onset intrauterine growth restriction? A prospective cohort study.
Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
J Obstet Gynaecol Res; 2013 May; 39(5):881-90. PubMed ID: 23496304
[TBL] [Abstract][Full Text] [Related]
17. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
Alahakoon TI; Zhang W; Trudinger BJ; Lee VW
J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
[TBL] [Abstract][Full Text] [Related]
18. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M
Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
[TBL] [Abstract][Full Text] [Related]
19. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia.
Molvarec A; Szarka A; Walentin S; Beko G; Karádi I; Prohászka Z; Rigó J
Reprod Biol Endocrinol; 2011 Sep; 9():124. PubMed ID: 21906313
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
Vatten LJ; Åsvold BO; Eskild A
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
